Risperidone vs olanzapina: un confronto di costo e di risultato nel trattamento ospedaliero della schizofrenia (Studio RODOS)

@article{Ravasio2003RisperidoneVO,
  title={Risperidone vs olanzapina: un confronto di costo e di risultato nel trattamento ospedaliero della schizofrenia (Studio RODOS)},
  author={Roberto Ravasio and Enrico Arrighi and Antonella Bitetto and D. Linciano and Am Lora and Marco Sacchi and Alberto Voltolini},
  journal={PharmacoEconomics Italian Research Articles},
  year={2003},
  volume={5},
  pages={81-94}
}
SummaryObjectivesTo compare costs and outcomes associated with treatment of schizophrenic inpatients with risperidone vs olanzapine.Materials and methodsA multicentre retrospective study was carried out in 242 inpatients affected by schizophrenia. Data were collected with reference to patients discharged from hospital or still hospitalized, both for a maximum treatment period of 120 days, and for whom either risperidone or olanzapine was the drug of first choice. Treatment outcomes, cost of… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.